Aclarion, Inc. (ACONW)Broomfield, United States | NasdaqCM
0.03 USD
+0.00
(8.984%)
⇧
(Oct. 14, 2026, 3:57 p.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 2:50 a.m. EDT
This security presents a catastrophic fundamental profile with no viable investment thesis. The company is generating massive losses, evidenced by a trailing EPS of -$6.58 and operating margins of -115%, while burning through cash at a rate of over $8 million annually against mere $84k in total revenue. The valuation metrics are nonsensical, showing a price-to-book ratio of 0.0037, which implies the market prices the company at less than 0.4% of its book value—a clear signal of severe distress or delisting risk rather than a bargain. With no dividend history, no analyst recommendations, and a beta of 1.2 indicating high volatility without the cushion of profitability, there is no margin of safety and no catalyst for recovery visible in the data. The recent price action shows the stock trading at its 52-week high, likely due to thin volume and speculative warrant activity rather than genuine demand, making it a dangerous speculative trap rather than a tradeable opportunity. |
| Attribute | Value |
|---|---|
| Revenue per Share | 0.057 |
| Beta | 1.21 |
| Previous Name | Coin Gabbar |
| Website | https://www.aclarion.com |
| Attribute | Value |
|---|---|
| Address1 | 8,181 Arista Place |
| Address2 | Suite 100 |
| Ask | 0.0 |
| Ask Size | 0 |
| Beta | 1.206 |
| Bid | 0.0 |
| Bid Size | 0 |
| Book Value | 6.905 |
| City | Broomfield |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.0279 |
| Current Ratio | 16.196 |
| Custom Price Alert Confidence | HIGH |
| Day High | 0.0279 |
| Day Low | 0.0279 |
| Ebitda | -9,468,166 |
| Ebitda Margins | 0.0 |
| Eps Trailing Twelve Months | -6.576 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Two Week High | 0.0279 |
| Fifty Two Week High Change | 0.0 |
| Fifty Two Week High Change Percent | 0.0 |
| Fifty Two Week Low | 0.0279 |
| Fifty Two Week Low Change | 0.0 |
| Fifty Two Week Low Change Percent | 0.0 |
| Fifty Two Week Range | 0.0279 - 0.0279 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,784,295,000,000 |
| Float Shares | 2,520,432 |
| Free Cashflow | -5,323,035 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 10 |
| Fullday Change | 0.0022999998 |
| Fullday Change Percent | 8.984375 |
| Fullday Price | 0.0279 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.21755 |
| Gross Profits | 18,224 |
| Has Pre Post Market Data | 1 |
| Industry | |
| Industry Key | |
| Language | en-US |
| Long Business Summary | Aclarion, Inc. operates as a healthcare technology company in the United States. It uses magnetic resonance spectroscopy (MRS) combined with proprietary signal-processing biomarkers to optimize clinical treatments. The company develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. It also provides NOCISCAN MRS Exam Protocol, a custom software protocol for using commercially available MRS pulse sequences in scanning intervertebral discs which extends the time of a standard lumbar MRI exam; and imaging data transfer products, including AMBRA Healthcare, a data transfer platform. In addition, the company offers The NOCISCAN Post-Processor Suite comprising NOCICALC, a Class I medical device that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra, and performs various degenerative pain biomarker calculations from those spectra, for each disc examined; and NOCIGRAM, which further processes the NOCICALC results into individual NOCISCORES, on a 0-10 scale, that represent the different relative levels of degenerative pain biomarkers the various discs examined in the patient. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado. |
| Long Name | Aclarion, Inc. |
| Market | us_market |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_108179695 |
| Name Change Date | 2,026-10-14 |
| Net Income To Common | -9,196,562 |
| Open | 0.048 |
| Operating Cashflow | -8,086,706 |
| Operating Margins | -115.031815 |
| Phone | 833 275 2266 |
| Prev Name | Coin Gabbar |
| Previous Close | 0.0256 |
| Price Hint | 4 |
| Price To Book | 0.00404055 |
| Profit Margins | 0.0 |
| Quick Ratio | 15.742 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0022999998 |
| Regular Market Change Percent | 8.984374 |
| Regular Market Day High | 0.0279 |
| Regular Market Day Low | 0.0279 |
| Regular Market Day Range | 0.0279 - 0.0279 |
| Regular Market Open | 0.048 |
| Regular Market Previous Close | 0.0256 |
| Regular Market Price | 0.0279 |
| Regular Market Time | 1,792,007,836 |
| Regular Market Volume | 11,408 |
| Return On Assets | -0.37014 |
| Return On Equity | -0.58966 |
| Revenue Growth | 0.305 |
| Revenue Per Share | 0.057 |
| Sand P52 Week Change | 0.1570785 |
| Sector | |
| Sector Key | |
| Source Interval | 15 |
| State | CO |
| Symbol | ACONW |
| Total Cash | 16,295,462 |
| Total Cash Per Share | 5.653 |
| Total Debt | 0 |
| Total Revenue | 83,769 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -6.576 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Type Disp | Equity |
| Volume | 11,408 |
| Website | https://www.aclarion.com |
| Zip | 80,021 |